Bromocriptine Mesylate Protects against Status Epilepticus and Temporal Lobe Epilepsy: Neurobehavioral, Histopathological and Neurochemical Evidences
Faheem Hyder Pottoo, Nahida Tabassum & Mohammad Maqbool Darziv · International Neuropsychiatric Disease Journal · 2016
Background: Dopamine (DA) plays a major role in the control of epileptic seizures arising in the limbic system, through D1/D2 receptor-mediated signaling. Objective: The study was intended to investigate whether bromocriptine mesylate (BRC), a dopamine (D2) receptor agonist, has...
Open access
Research Article
10.9734/INDJ/2016/24401